Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description adds extensive behavioral context beyond annotations: it details the data sources (EDGAR/XBRL for companies, FAERS for drugs), the specific financial metrics and counts retrieved, handling of off-calendar fiscal years, sorting by primary metric, and output format with citation URIs. No contradiction with readOnlyHint, openWorldHint, idempotentHint, or destructiveHint.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is clear and well-structured, starting with example queries and ending with output details. While it packs substantial information, it is slightly lengthy but remains effective and front-loaded.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite lacking an output schema, the description fully explains the returned data: paired data per entity, citation URIs, and sorting behavior. It covers both entity types comprehensively, making it self-sufficient for an agent to understand what the tool returns.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

With 100% schema coverage, the description still adds significant value by explaining the semantics of each type ('company' vs 'drug') and giving concrete examples for values (tickers for companies, drug names). It also clarifies array constraints (min 2, max 5).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly defines the tool's purpose: side-by-side comparison of 2-5 companies or drugs in one parallel call. It uses specific verbs like 'compare' and 'rank' and distinguishes from sibling tools by explicitly stating preference over sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides strong usage guidance, listing typical user queries ('X vs Y', 'which is bigger') and explicitly instructing to prefer this tool over sequential lookups. It does not explicitly state when not to use it, but the input schema's max of 5 entities is implied.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Many tools overlap significantly in purpose, especially the ask_pipeworx variants (standard, beta, grounded) and deep_research, as well as the polymarket arbitrage/edges/fill_risk/kalshi_spread suite. It would be hard for an agent to reliably choose the correct tool without deep understanding of subtle distinctions.

Naming Consistency3/5

Tool names mostly use snake_case, but there is no consistent prefix or verb pattern. Some names are descriptive phrases (e.g., scream_void_scream, compare_entities) while others are vague (e.g., forget, recall). The mix of 'pipeworx_' prefix on some tools and lack of it on others adds inconsistency.

Tool Count3/5

32 tools is on the high side for a data research server, given the overlapping functionality. Some tools could be merged (e.g., the ask_pipeworx variants, polymarket tools). However, the count is not excessive enough to be unmanageable, and each tool serves a specific niche.

Completeness4/5

The server covers a broad range of data sources and prediction market analysis, with tools for research, comparison, monitoring, and memory. Minor gaps exist (e.g., no tool to update stored memories or manage subscriptions beyond CRUD), but core workflows are well-supported.